Antipsychotic clozapine inhibits the function of α7-nicotinic acetylcholine receptors

Neuropharmacology

Volumn 52, Issue 2, 2007, Pages 387-394

  Singhal, Sachin K ^a   Zhang, Li ^a   Morales, Marisela ^b   Oz, Murat ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Antipsychotic; Clozapine; Nicotinic receptors; Xenopus oocyte

Indexed keywords

BUNGAROTOXIN RECEPTOR; CALCIUM; CHLORIDE CHANNEL; CLOZAPINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; NEUROLEPTIC AGENT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; IC 50; MALE; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; VOLTAGE CLAMP;

ANIMALS; ANIMALS, NEWBORN; ANTIPSYCHOTIC AGENTS; CHOLINE; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG INTERACTIONS; FEMALE; HIPPOCAMPUS; INHIBITORY CONCENTRATION 50; MALE; MEMBRANE POTENTIALS; MICROINJECTIONS; NICOTINE; NICOTINIC AGONISTS; NOOTROPIC AGENTS; OOCYTES; PATCH-CLAMP TECHNIQUES; PYRAMIDAL CELLS; RATS; RECEPTORS, NICOTINIC; XENOPUS LAEVIS;

EID: 33846459006     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.08.023     Document Type: Article

References (43)

1. Adler L.E., Olincy A., Waldo M., Harris J.G., Griffith J., Stevens K., Flach K., Nagamoto H., Bickford P., Leonard S., and Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull. 24 (1998) 189-202
2. Alkondon M., and Albuquerque E.X. The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog. Brain Res. 145 (2004) 109-120
3. 2+ influx. Biochem. J. 274 (1991) 193-197
4. Ashby C.R., and Wang R.Y. Pharmacological actions of the atypical antipsychotic drug clozapine: a review. Synapse 24 (1996) 349-394
5. Asproni B., Pau A., Bitti M., Melosu M., Cerri R., Dazzi L., Seu E., Maciocco E., Sanna E., Busonero F., Talani G., Pusceddu L., Altomare C., Trapani G., and Biggio G. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors. J. Med. Chem. 45 (2002) 4655-4668
6. Baldessarini R.J., Centorrino F., Flood J.G., Volpicelli S.A., Houston-Lyons D., and Cohen B.M. Tissue concentrations of clozapine and it's metabolites in the rat. Neuropsychopharmacology 9 (1993) 117-124
7. Dani J.A. Overview of nicotinic receptors and their roles in the central nervous system. Biol. Psychiatry 49 (2001) 166-174
8. Dascal N. The use of Xenopus oocytes for the study of ion channels. CRC Crit. Rev. Biochem. 22 (1987) 317-387
9. Fraser S.P., and Djamgoz M.B.A. Xenopus oocytes: endogenous electrophysiological characteristics. In: Osborne N.N. (Ed). Current Aspects of the Neurosciences vol. 4 (1992), Macmillan Press 267-315
10. Freedman R., Adams C.E., and Leonard S. The alpha7-nicotinic acetylcholine receptor and the pathology of hippocampal interneurons in schizophrenia. J. Chem. Neuroanat. 20 (2000) 299-306
11. Fujii S., Ji Z., and Sumikawa K. Inactivation of alpha7 ACh receptors and activation of non-alpha7 ACh receptors both contribute to long term potentiation induction in the hippocampal CA1 region. Neurosci. Lett. 286 (2000) 134-138
12. George T.P., Sernyak M.J., Ziedonis D.M., and Woods S.W. Effects of clozapine on smoking in chronic schizophrenic outpatients. J. Clin. Psychiatry 56 (1995) 344-346
13. George T.P., Ziedonis D.M., Feingold A., Pepper W.T., Satterburg C.A., Winkel J., Rounsaville B.J., and Kosten T.R. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am. J. Psychiatry 157 (2000) 1835-1842
14. Guan X., Nakauchi S., and Sumikawa K. Nicotine reverses consolidated long-term potentiation in the hippocampal CA1 region. Brain Res. 1078 (2006) 80-91
15. Hermann B., Wetzel C.H., Pestel E., Zieglgansberger W., Holsboer F., and Rupprecht R. Functional antagonistic properties of clozapine at the 5-HT3 receptor. Biochem. Biophys. Res. Commun. 225 (1996) 957-960
16. Khan A.Y., and Preskorn S.H. Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring. J. Psychiatr. Pract. 11 (2005) 289-301
17. Levin E.D. Nicotinic receptor subtypes and cognitive function. J. Neurobiol. 53 (2002) 633-640
18. Levine J.B., Martin G., Wilson A., and Treistman S.N. Clozapine inhibits isolated N-methyl-D-aspartate receptors expressed in xenopus oocytes in a subunit specific manner. Neurosci. Lett. 346 (2003) 125-128
19. Martin L.F., Kem W.R., and Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) 174 (2004) 54-64
20. McEvoy J.P., and Allen T.B. The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome. Curr. Drug Target CNS Neurol. Disord. 1 (2002) 433-442
21. McGehee D.S., Heath M.J.S., Gelber S., Devay P., and Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Nature 269 (1995) 1692-1696
22. Meltzer H.Y. Treatment-resistant schizophrenia-the role of clozapine. Curr. Med. Res. Opin. 14 (1997) 1-20
23. Meltzer H.Y., Park S., and Kessler R. Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 13591-13593
24. Miyamoto S., Duncan G.E., Marx C.E., and Lieberman J.A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol. Psychiatry 10 (2005) 79-104
25. Morales M., and Bloom F.E. The 5-HT3 receptor is present in different subpopulations of GABAergic neurons in the rat telencephalon. J. Neurosci. 17 (1997) 3157-3167
26. Nagamoto H.T., Adler L.E., Hea R.A., Griffith J.M., McRae K.A., and Freedman R. Gating of auditory P50 in schizophrenics: unique effects of clozapine. Biol. Psychiatry 40 (1996) 181-188
27. Nguyen Q.T., and Miledi R. Inhibition of skeletal muscle nicotinic receptors by the atypical antipsychotic clozapine. Neuropharmacology 42 (2002) 662-669
28. Olincy A., Ross R.G., Young D.A., Roath M., and Freedman R. Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients. Neuropsychopharmacology 18 (1998) 175-185
29. 1A receptor co-expressed in Xenopus oocytes. Mol. Pharmacol. 54 (1998) 1106-1112
30. Oz M., Ravindran R., Zhang L., and Morales M. Endogenous cannabinoid, anandamide inhibits neuronal nicotinic acetylcholine receptor-mediated responses in Xenopus oocytes. J. Pharmacol. Exp. Ther. 306 (2003) 1003-1010
31. Oz M., Spivak C.E., and Lupica C.R. Tween 80 is a potent inhibitor of α7-nicotinic acetylcholine receptor-mediated currents in Xenopus oocytes. J. Neurosci. Methods 137 (2004) 167-173
32. Oz M., Yang K.-H., O'Donovan M., and Renaud L.P. Presynaptic angiotensin II AT1 receptors enhance inhibitory and excitatory synaptic events on motoneurons and other ventral horn neurons in neonatal rat spinal cord. J. Neurophysiol. 94 (2005) 1405-1412
33. Pochet S., Garcia-Marcos M., Fernandez M., Marino A., and Dehaye J.P. Regulation by clozapine of calcium handling by rat submandibular acinar cells. Cell Calcium 34 (2003) 465-475
34. Procyshyn R.M., Ihsan N., and Thompson D. A comparison of smoking behaviours between patients treated with clozapine and depot neuroleptics. Int. Clin. Psychopharmacol. 16 (2001) 291-294
35. Rammes G., Eisensamer B., Ferrari U., Shapa M., Gimpl G., Gilling K., Parsons C., Riering K., Hapfelmeier G., Bondy B., Zieglgansberger W., Holsboer F., and Rupprecht R. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner. Mol. Psychiatry 9 (2004) 846-858
36. Ripoll N., Bronnec M., and Bourin M. Nicotinic receptors and schizophrenia. Curr. Med. Res. Opin. 20 (2004) 1057-1074
37. Role L.W., and Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16 (1996) 1077-1085
38. 7 expressed in Xenopus oocytes. Biophys. J. 65 (1993) 2614-2621
39. Séguéla P., Wadiche J., Dineley-Miller K., Dani J.A., and Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain alpha 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13 (1993) 596-604
40. 2+ uptake and catecholamine secretion by phenothiazines and pimozide in adrenal medulla cells cultures. Cell Calcium 3 (1982) 183-190
41. Staubli U., and Xu F.B. Effects of 5-HT3 receptor antagonism on hippocampal theta rhythm, memory, and LTP induction in the freely moving rat. J. Neurosci. 15 (1995) 2445-2452
42. Titier K., Canal M., Deridet E., Abouelfath A., Gromb S., Molimard M., and Moore N. Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice. Toxicol. Appl. Pharmacol. 199 (2004) 52-60
43. - current in rat dorsal root ganglion neurons: differences between some neuroleptics. Br. J. Pharmacol. 135 (2002) 1547-1555